Amring Pharmaceuticals Inc recalls Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals…
- Recall date
- June 12, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0871-2023
- FDA classification
- Class III
- Brand / firm
- Amring Pharmaceuticals Inc
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Get recall alerts
Free email alert whenever Amring Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Amring Pharmaceuticals Inc